Figure 4
Figure 4. Partially impaired CD4+CD25+ Treg function in p110γKOδD910A mice. (A-C) Cells from thymus, spleen, and lymph nodes of WT and p110γKOδD910A mice were stained with fluorescence-conjugated antibodies against surface marker CD4, et al. (A). Percentage of Foxp3+ cells gated from CD4+CD8− cells in thymus or CD4+ cells in spleen and lymph nodes. (B,C) Mean fluorescent intensity of Foxp3 and GITR on CD4+CD8−CD25+ cells in thymus or CD4+CD25+ cells in spleen and lymph nodes. (D) Purified 5 × 104 CD4+CD25+ and/or CD4+CD25− cells from WT or p110γKOδD910A (−/−) mice were incubated with T-cell–depleted and mitomycin-treated splenocytes and 1 μg/mL α-CD3 in 96-well plate for 72 hours for measuring proliferation. (E,F) TNF-α and Il-4 produced by T cells shown in panel D. Data represent at least 2 experiments with triplicates for each sample (± SEM). ■ represents WT; □, p110γKOδD910A.

Partially impaired CD4+CD25+ Treg function in p110γKOδD910A mice. (A-C) Cells from thymus, spleen, and lymph nodes of WT and p110γKOδD910A mice were stained with fluorescence-conjugated antibodies against surface marker CD4, et al. (A). Percentage of Foxp3+ cells gated from CD4+CD8 cells in thymus or CD4+ cells in spleen and lymph nodes. (B,C) Mean fluorescent intensity of Foxp3 and GITR on CD4+CD8CD25+ cells in thymus or CD4+CD25+ cells in spleen and lymph nodes. (D) Purified 5 × 104 CD4+CD25+ and/or CD4+CD25 cells from WT or p110γKOδD910A (−/−) mice were incubated with T-cell–depleted and mitomycin-treated splenocytes and 1 μg/mL α-CD3 in 96-well plate for 72 hours for measuring proliferation. (E,F) TNF-α and Il-4 produced by T cells shown in panel D. Data represent at least 2 experiments with triplicates for each sample (± SEM). ■ represents WT; □, p110γKOδD910A.

Close Modal

or Create an Account

Close Modal
Close Modal